Having worked in the NHS and spent eight years coordinating patient services in the private sector, I have seen a lot of confusion regarding how medical cannabis is accessed in the UK. Many patients arrive at our doors thinking they can simply purchase a “medical card” or that approval is a quick, guaranteed formality. It isn’t.
To help you navigate this, we need to clear up some terminology first. Understanding the process is your best defence against misinformation.
Defining Your Terms
- Medical Cannabis (CBPM): This stands for Cannabis-based products for medicinal use. These are strictly regulated, pharmaceutical-grade products.
- Private Specialist Clinic: A CQC-registered (Care Quality Commission) facility where doctors—usually on the General Medical Council (GMC) Specialist Register—assess patients for specific, chronic conditions.
- GMC Standards: The code of practice that all UK doctors must follow. It mandates that any treatment provided must be safe, clinically necessary, and evidence-based.
- MDT (Multi-Disciplinary Team): A group of professionals, often including a lead consultant and a pharmacist, who review a patient’s case to ensure the prescription is safe and appropriate.
Common Patient Misunderstandings
Before we dive into the process, let’s clear the air. These are the top five things I hear from patients that are simply not true:
The Prescription-First Pathway
In the UK, medical cannabis is legal only under the supervision of a specialist doctor. It is not an “over-the-counter” medicine. The pathway is strictly “prescription-first,” meaning that without a clinical consultation, there is no legal path to access. A legitimate clinic will always follow a structured, clinical route.
What the Process Looks Like
When you contact a clinic, they should walk you through a specific sequence. If they skip these steps, you should treat it as a red flag.
How to Spot a Responsible Clinic: A Checklist
Use this table to assess whether the clinic you are looking at is operating with the proper clinical rigour.
Why the “Additional Review” Step is Vital
The “additional review” step is where the clinic proves it is following GMC standards. By having a second specialist review the case, the clinic ensures that the prescribing doctor is acting within the bounds of safety. It prevents “rogue” prescribing. If a clinic tells you that the specialist’s decision is final and no further internal review is required, they are likely prioritising speed over safety.


The Medical Records Step: Why It’s Non-Negotiable
I cannot stress this enough: any doctor who prescribes herald-dispatch.com you medication without looking at your NHS medical history is potentially committing malpractice. Your history reveals contraindications—other drugs you take, past heart issues, or mental health history that might make cannabis unsafe for you. If a clinic suggests you don’t need to involve your GP, walk away immediately. It is unsafe and unprofessional.
What Happens Next?
If you have already contacted a clinic and they haven’t asked for your GP records within the first 48 hours, or if they haven’t explained the role of the pharmacy in the process, contact them and ask: “What is your internal MDT process for reviewing my case?” If they cannot answer clearly, you have your answer.
Conclusion
Accessing medical cannabis in the UK is a clinical journey, not a retail one. While it can be frustrating to wait for records or go through an additional review, these steps exist to keep you safe and to ensure that you are receiving high-quality, pharmaceutical-grade care. Ignore the “quick fix” clinics. Look for those that prioritise GMC standards, require your full medical history, and involve an MDT in their approval process. Your health is not worth taking shortcuts for.
Disclaimer: This article is for information purposes only and does not constitute medical advice. Always consult with a registered healthcare professional regarding your specific health needs.